- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2.
January 24, 2020
Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma.
January 23, 2020
HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma.
January 23, 2020
MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
January 23, 2020
Split Renal Function in Patients with Renal Masses: Utility of Parenchymal Volume Analysis versus Nuclear Renal Scans.
January 23, 2020
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma.
January 23, 2020
Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma.
January 22, 2020
A historical turning point for the treatment of advanced renal cell carcinoma: ınhibition of ımmune checkpoint.
January 22, 2020
Renal Neuroendocrine Neoplasms: A Single-center Experience.
January 21, 2020
Establishment of cohesion 1 homolog 2 facilitates cell aggressive behaviors and induces poor prognosis in renal cell carcinoma.
January 21, 2020
A Near Infrared-Peptide Probe with Tumor-Specific Excretion Retarded Effect for Image-Guided Surgery of Renal Cell Carcinoma.
January 20, 2020
TMSB10 promotes migration and invasion of cancer cells and is a novel prognostic marker for renal cell carcinoma.
January 20, 2020
Combined induction with anti-PD-1 and anti-CTLA-4 antibodies provides synergistic antitumor effects in DC-CIK cells in renal carcinoma cell lines.
January 20, 2020
Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma.
January 17, 2020